| [1] | Stevenson PG, Simas JP, Efstathiou S (2009) Immune control of mammalian gamma-herpesviruses: lessons from murid herpesvirus-4. J Gen Virol 90: 2317–2330. doi: 10.1099/vir.0.013300-0
|
| [2] | Bollard CM, Rooney CM, Heslop HE (2012) T-cell therapy in the treatment of post-transplant lymphoproliferative disease. Nat Rev Clin Oncol 9: 510–519. doi: 10.1038/nrclinonc.2012.111
|
| [3] | Thorley-Lawson DA (2001) Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 1: 75–82. doi: 10.1038/35095584
|
| [4] | Simas JP, Efstathiou S (1998) Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis. Trends Microbiol 6: 276–282. doi: 10.1016/s0966-842x(98)01306-7
|
| [5] | Speck SH, Ganem D (2010) Viral latency and its regulation: lessons from the gamma-herpesviruses. Cell Host Microbe 8: 100–115. doi: 10.1016/j.chom.2010.06.014
|
| [6] | Nash AA, Dutia BM, Stewart JP, Davison AJ (2001) Natural history of murine gamma-herpesvirus infection. Philos Trans R Soc Lond B Biol Sci 356: 569–579. doi: 10.1098/rstb.2000.0779
|
| [7] | Virgin HWt, Latreille P, Wamsley P, Hallsworth K, Weck KE, et al. (1997) Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71: 5894–5904.
|
| [8] | Simas JP, Marques S, Bridgeman A, Efstathiou S, Adler H (2004) The M2 gene product of murine gammaherpesvirus 68 is required for efficient colonization of splenic follicles but is not necessary for expansion of latently infected germinal centre B cells. J Gen Virol 85: 2789–2797. doi: 10.1099/vir.0.80138-0
|
| [9] | Flano E, Kim IJ, Woodland DL, Blackman MA (2002) Gamma-herpesvirus latency is preferentially maintained in splenic germinal center and memory B cells. J Exp Med 196: 1363–1372. doi: 10.1084/jem.20020890
|
| [10] | Marques S, Efstathiou S, Smith KG, Haury M, Simas JP (2003) Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes. J Virol 77: 7308–7318. doi: 10.1128/jvi.77.13.7308-7318.2003
|
| [11] | Bennett NJ, May JS, Stevenson PG (2005) Gamma-herpesvirus latency requires T cell evasion during episome maintenance. PLoS Biol 3: e120. doi: 10.1371/journal.pbio.0030120
|
| [12] | Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, et al. (1995) Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375: 685–688. doi: 10.1038/375685a0
|
| [13] | Hislop AD, Ressing ME, van Leeuwen D, Pudney VA, Horst D, et al. (2007) A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates. J Exp Med 204: 1863–1873. doi: 10.1084/jem.20070256
|
| [14] | Horst D, van Leeuwen D, Croft NP, Garstka MA, Hislop AD, et al. (2009) Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation. J Immunol 182: 2313–2324. doi: 10.4049/jimmunol.0803218
|
| [15] | Croft NP, Shannon-Lowe C, Bell AI, Horst D, Kremmer E, et al. (2009) Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle. PLoS Pathog 5: e1000490. doi: 10.1371/journal.ppat.1000490
|
| [16] | Zuo J, Currin A, Griffin BD, Shannon-Lowe C, Thomas WA, et al. (2009) The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation. PLoS Pathog 5: e1000255. doi: 10.1371/journal.ppat.1000255
|
| [17] | Zuo J, Quinn LL, Tamblyn J, Thomas WA, Feederle R, et al. (2011) The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways. J Virol 85: 1604–1614. doi: 10.1128/jvi.01608-10
|
| [18] | Fruh K, Bartee E, Gouveia K, Mansouri M (2002) Immune evasion by a novel family of viral PHD/LAP-finger proteins of gamma-2 herpesviruses and poxviruses. Virus Res 88: 55–69. doi: 10.1016/s0168-1702(02)00120-x
|
| [19] | Boname JM, Stevenson PG (2001) MHC class I ubiquitination by a viral PHD/LAP finger protein. Immunity 15: 627–636. doi: 10.1016/s1074-7613(01)00213-8
|
| [20] | Boname JM, de Lima BD, Lehner PJ, Stevenson PG (2004) Viral degradation of the MHC class I peptide loading complex. Immunity 20: 305–317. doi: 10.1016/s1074-7613(04)00047-0
|
| [21] | Boname JM, May JS, Stevenson PG (2005) The murine gamma-herpesvirus-68 MK3 protein causes TAP degradation independent of MHC class I heavy chain degradation. Eur J Immunol 35: 171–179. doi: 10.1002/eji.200425459
|
| [22] | Stevenson PG, May JS, Smith XG, Marques S, Adler H, et al. (2002) K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus. Nat Immunol 3: 733–740. doi: 10.1038/ni818
|
| [23] | Rodrigues L, Pires de Miranda M, Caloca MJ, Bustelo XR, Simas JP (2006) Activation of Vav by the gammaherpesvirus M2 protein contributes to the establishment of viral latency in B lymphocytes. J Virol 80: 6123–6135. doi: 10.1128/jvi.02700-05
|
| [24] | Pires de Miranda M, Lopes FB, McVey CE, Bustelo XR, Simas JP (2013) Role of Src homology domain binding in signaling complexes assembled by the murid gamma-herpesvirus M2 protein. J Biol Chem 288: 3858–3870. doi: 10.1074/jbc.m112.439810
|
| [25] | Siegel AM, Herskowitz JH, Speck SH (2008) The MHV68 M2 protein drives IL-10 dependent B cell proliferation and differentiation. PLoS Pathog 4: e1000039. doi: 10.1371/journal.ppat.1000039
|
| [26] | Rangaswamy US, Speck SH (2014) Murine gammaherpesvirus M2 protein induction of IRF4 via the NFAT pathway leads to IL-10 expression in B cells. PLoS Pathog 10: e1003858. doi: 10.1371/journal.ppat.1003858
|
| [27] | Burkhardt AL, Bolen JB, Kieff E, Longnecker R (1992) An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. J Virol 66: 5161–5167.
|
| [28] | Lee H, Guo J, Li M, Choi JK, DeMaria M, et al. (1998) Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Mol Cell Biol 18: 5219–5228.
|
| [29] | Marques S, Alenquer M, Stevenson PG, Simas JP (2008) A single CD8+ T cell epitope sets the long-term latent load of a murid herpesvirus. PLoS Pathog 4: e1000177. doi: 10.1371/journal.ppat.1000177
|
| [30] | Wang X, Liu X, Jia Y, Chao Y, Xing X, et al. (2010) Widespread sequence variation in the Epstein-Barr virus latent membrane protein 2A gene among northern Chinese isolates. J Gen Virol 91: 2564–2573. doi: 10.1099/vir.0.021881-0
|
| [31] | Stebbing J, Bourboulia D, Johnson M, Henderson S, Williams I, et al. (2003) Kaposi's sarcoma-associated herpesvirus cytotoxic T lymphocytes recognize and target Darwinian positively selected autologous K1 epitopes. J Virol 77: 4306–4314. doi: 10.1128/jvi.77.7.4306-4314.2003
|
| [32] | Guihot A, Dupin N, Marcelin AG, Gorin I, Bedin AS, et al. (2006) Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma. J Infect Dis 194: 1078–1088. doi: 10.1086/507648
|
| [33] | Brander C, O'Connor P, Suscovich T, Jones NG, Lee Y, et al. (2001) Definition of an optimal cytotoxic T lymphocyte epitope in the latently expressed Kaposi's sarcoma-associated herpesvirus kaposin protein. J Infect Dis 184: 119–126. doi: 10.1086/322003
|
| [34] | Husain SM, Usherwood EJ, Dyson H, Coleclough C, Coppola MA, et al. (1999) Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8(+) T lymphocytes. Proc Natl Acad Sci U S A 96: 7508–7513. doi: 10.1073/pnas.96.13.7508
|
| [35] | Usherwood EJ, Roy DJ, Ward K, Surman SL, Dutia BM, et al. (2000) Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells. J Exp Med 192: 943–952. doi: 10.1084/jem.192.7.943
|
| [36] | Stevenson PG, Cardin RD, Christensen JP, Doherty PC (1999) Immunological control of a murine gammaherpesvirus independent of CD8+ T cells. J Gen Virol 80 (Pt 2) 477–483.
|
| [37] | Tibbetts SA, van Dyk LF, Speck SH, Virgin HWt (2002) Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus. J Virol 76: 7125–7132. doi: 10.1128/jvi.76.14.7125-7132.2002
|
| [38] | Midgley RS, Bell AI, McGeoch DJ, Rickinson AB (2003) Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes. J Virol 77: 11517–11530. doi: 10.1128/jvi.77.21.11517-11530.2003
|
| [39] | Midgley RS, Bell AI, Yao QY, Croom-Carter D, Hislop AD, et al. (2003) HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences. J Virol 77: 11507–11516. doi: 10.1128/jvi.77.21.11507-11516.2003
|
| [40] | Chen Y, Yao K, Wang B, Qing J, Liu G (2008) Potent dendritic cell vaccine loaded with latent membrane protein 2A (LMP2A). Cell Mol Immunol 5: 365–372. doi: 10.1038/cmi.2008.45
|
| [41] | Vigano S, Utzschneider DT, Perreau M, Pantaleo G, Zehn D, et al. (2012) Functional avidity: a measure to predict the efficacy of effector T cells? Clin Dev Immunol 2012: 153863. doi: 10.1155/2012/153863
|
| [42] | Matsumura M, Saito Y, Jackson MR, Song ES, Peterson PA (1992) In vitro peptide binding to soluble empty class I major histocompatibility complex molecules isolated from transfected Drosophila melanogaster cells. J Biol Chem 267: 23589–23595.
|
| [43] | Schumacher TN, Heemels MT, Neefjes JJ, Kast WM, Melief CJ, et al. (1990) Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell 62: 563–567. doi: 10.1016/0092-8674(90)90020-f
|
| [44] | Chen W, Khilko S, Fecondo J, Margulies DH, McCluskey J (1994) Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J Exp Med 180: 1471–1483. doi: 10.1084/jem.180.4.1471
|
| [45] | Fremont DH, Stura EA, Matsumura M, Peterson PA, Wilson IA (1995) Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc Natl Acad Sci U S A 92: 2479–2483. doi: 10.1073/pnas.92.7.2479
|
| [46] | Alam SM, Travers PJ, Wung JL, Nasholds W, Redpath S, et al. (1996) T-cell-receptor affinity and thymocyte positive selection. Nature 381: 616–620. doi: 10.1038/381616a0
|
| [47] | Zehn D, Lee SY, Bevan MJ (2009) Complete but curtailed T-cell response to very low-affinity antigen. Nature 458: 211–214. doi: 10.1038/nature07657
|
| [48] | Jameson SC, Carbone FR, Bevan MJ (1993) Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J Exp Med 177: 1541–1550. doi: 10.1084/jem.177.6.1541
|
| [49] | Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, et al. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76: 17–27. doi: 10.1016/0092-8674(94)90169-4
|
| [50] | Collins CM, Boss JM, Speck SH (2009) Identification of infected B-cell populations by using a recombinant murine gammaherpesvirus 68 expressing a fluorescent protein. J Virol 83: 6484–6493. doi: 10.1128/jvi.00297-09
|
| [51] | Stevenson PG, Belz GT, Altman JD, Doherty PC (1999) Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gamma-herpesvirus infection. Eur J Immunol 29: 1059–1067. doi: 10.1002/(sici)1521-4141(199904)29:04<1059::aid-immu1059>3.0.co;2-l
|
| [52] | Price DA, Brenchley JM, Ruff LE, Betts MR, Hill BJ, et al. (2005) Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J Exp Med 202: 1349–1361. doi: 10.1084/jem.20051357
|
| [53] | Callan MF, Steven N, Krausa P, Wilson JD, Moss PA, et al. (1996) Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med 2: 906–911. doi: 10.1038/nm0896-906
|
| [54] | Hislop AD, Taylor GS, Sauce D, Rickinson AB (2007) Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 25: 587–617. doi: 10.1146/annurev.immunol.25.022106.141553
|
| [55] | Ehtisham S, Sunil-Chandra NP, Nash AA (1993) Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J Virol 67: 5247–5252.
|
| [56] | Frederico B, Chao B, May JS, Belz GT, Stevenson PG (2014) A murid gamma-herpesviruses exploits normal splenic immune communication routes for systemic spread. Cell Host Microbe 15: 457–470. doi: 10.1016/j.chom.2014.03.010
|
| [57] | Smith CM, Gill MB, May JS, Stevenson PG (2007) Murine gammaherpesvirus-68 inhibits antigen presentation by dendritic cells. PLoS ONE 2: e1048. doi: 10.1371/journal.pone.0001048
|
| [58] | El-Gogo S, Flach B, Staib C, Sutter G, Adler H (2008) In vivo attenuation of recombinant murine gammaherpesvirus 68 (MHV-68) is due to the expression and immunogenicity but not to the insertion of foreign sequences. Virology 380: 322–327. doi: 10.1016/j.virol.2008.07.034
|
| [59] | Loh J, Popkin DL, Droit L, Braaten DC, Zhao G, et al. (2012) Specific mutation of a gammaherpesvirus-expressed antigen in response to CD8 T cell selection in vivo. J Virol 86: 2887–2893. doi: 10.1128/jvi.06101-11
|
| [60] | Cardin RD, Brooks JW, Sarawar SR, Doherty PC (1996) Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J Exp Med 184: 863–871. doi: 10.1084/jem.184.3.863
|
| [61] | Belz GT, Stevenson PG, Castrucci MR, Altman JD, Doherty PC (2000) Postexposure vaccination massively increases the prevalence of gamma-herpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice. Proc Natl Acad Sci U S A 97: 2725–2730. doi: 10.1073/pnas.040575197
|
